Breaking News

CDMO Northway Biotech Expands in U.S.

Opens new biopharmaceutical manufacturing site in greater Boston area.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), established in 2004, with an EMA and FDA-compliant, state-of-the-art, cGMP manufacturing site in Europe, has opened its new 30,000-square-foot process development and cGMP manufacturing site in Waltham, MA.   From cell line development to cGMP DS manufacturing and aseptic filling, the state-of-the-art facility, in the booming biotech hub in the Greater Boston area, will provide end-to-end services f...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters